🇺🇸 FDA

Drug profile · INN

irbesartan: hydrochlorothiazide

IRBESARTAN; HYDROCHLOROTHIAZIDE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

irbesartan: hydrochlorothiazide (IRBESARTAN; HYDROCHLOROTHIAZIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN irbesartan: hydrochlorothiazide
Brand IRBESARTAN; HYDROCHLOROTHIAZIDE
Route ORAL
Formulation TABLET

Frequently asked questions

What is irbesartan: hydrochlorothiazide?

irbesartan: hydrochlorothiazide (IRBESARTAN; HYDROCHLOROTHIAZIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for irbesartan: hydrochlorothiazide?

IRBESARTAN; HYDROCHLOROTHIAZIDE is a marketed brand name for irbesartan: hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of irbesartan: hydrochlorothiazide?

irbesartan: hydrochlorothiazide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.